| |
|
|
| Name: |
Casdin Capital LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10019 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
40 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
RVMD |
Revolution Medicines, Inc. |
1 |
- |
$35.96 |
$163,900,000 |
5,714,775 |
16.16% |
113,799,000 |
3,904,775 |
4.989 |
N/A |
|
|
BLFS |
Biolife Solutions Inc |
2 |
- |
$17.53 |
$141,491,000 |
8,707,165 |
13.95% |
34,049,000 |
927,165 |
20.905 |
Biotechnology |
|
|
SRPT |
Sarepta Therapeutics Inc |
3 |
- |
$128.77 |
$97,057,000 |
1,006,500 |
9.57% |
-25,415,000 |
-3,830 |
1.196 |
Drug Manufacturers - ... |
|
|
RLAY |
Relay Therapeutics, Inc. |
4 |
- |
$6.37 |
$81,341,000 |
7,387,943 |
8.02% |
23,114,000 |
464,369 |
5.458 |
N/A |
|
|
GPCR |
Structure Therapeutics Inc. |
5 |
- |
$38.94 |
$44,504,000 |
1,091,867 |
4.39% |
-17,453,000 |
-166,299 |
2.853 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
6 |
- |
$20.76 |
$44,211,000 |
1,450,000 |
4.36% |
6,960,000 |
271,925 |
1.619 |
N/A |
|
|
ILMN |
Illumina Inc |
7 |
- |
$122.28 |
$43,582,000 |
313,000 |
4.3% |
40,150,000 |
288,000 |
0.214 |
Scientific & Technica... |
|
|
VERV |
Verve Therapeutics, Inc. |
8 |
- |
$0.00 |
$41,947,000 |
3,009,094 |
4.14% |
2,768,000 |
54,384 |
4.528 |
N/A |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
9 |
- |
$143.31 |
$37,325,000 |
195,000 |
3.68% |
1,905,000 |
-5,000 |
0.158 |
Biotechnology |
|
|
SLGC |
Cm Life Sciences Ii Inc. |
10 |
- |
$2.10 |
$31,889,000 |
12,604,275 |
3.14% |
1,765,000 |
0 |
6.958 |
N/A |
|
|
EXAS |
Exact Sciences Corp |
11 |
- |
$58.85 |
$31,072,000 |
420,000 |
3.06% |
-272,000 |
-39,450 |
0.236 |
Biotechnology |
|
|
BPMC |
Blueprint Medicines Corp |
12 |
- |
$93.00 |
$30,105,000 |
326,378 |
2.97% |
11,454,000 |
-45,000 |
0.494 |
N/A |
|
|
PLRX |
Pliant Therapeutics, Inc. |
13 |
- |
$0.00 |
$28,561,000 |
1,577,108 |
2.82% |
1,214,000 |
0 |
2.507 |
N/A |
|
|
DNLI |
Denali Therapeutics Inc. |
14 |
- |
$15.43 |
$27,898,000 |
1,300,000 |
2.75% |
1,079,000 |
0 |
1.084 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
15 |
- |
$0.00 |
$20,945,000 |
1,033,811 |
2.07% |
7,785,000 |
0 |
3.192 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
16 |
- |
$0.00 |
$20,676,000 |
6,381,377 |
2.04% |
4,403,000 |
0 |
9.972 |
N/A |
|
|
BEAM |
Beam Therapeutics Inc. |
17 |
- |
$21.38 |
$14,372,000 |
528,000 |
1.42% |
663,000 |
-42,000 |
0.838 |
N/A |
|
|
ABCL |
Abcellera Biologics Inc. |
18 |
- |
$0.00 |
$13,476,000 |
2,360,129 |
1.33% |
2,619,000 |
0 |
0.877 |
N/A |
|
|
TNGX |
Tango Therapeutics Ord Shs |
19 |
- |
$0.00 |
$11,765,000 |
1,188,349 |
1.16% |
-2,956,000 |
-119,000 |
1.357 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
20 |
- |
$0.00 |
$10,645,000 |
3,206,380 |
1.05% |
4,232,000 |
0 |
5.849 |
N/A |
|
|
RNA |
Avidity Biosciences, Inc. |
21 |
- |
$24.36 |
$10,641,000 |
1,175,750 |
1.05% |
2,666,000 |
-74,250 |
1.479 |
N/A |
|
|
NGNE |
Neurogene |
22 |
New |
$3.68 |
$10,167,000 |
524,616 |
1% |
10,167,000 |
524,616 |
1.252 |
N/A |
|
|
PACB |
Pacific Biosciences Of Cali... |
23 |
- |
$1.47 |
$10,162,000 |
1,035,859 |
1% |
1,513,000 |
0 |
0.391 |
Biotechnology |
|
|
WGS |
GeneDx Holdings Corp |
24 |
- |
$11.08 |
$8,513,000 |
3,095,511 |
0.84% |
-2,755,000 |
0 |
12.097 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
25 |
- |
$3.80 |
$7,667,000 |
2,050,000 |
0.76% |
3,321,000 |
0 |
1.73 |
Biotechnology |
|
|
CDXS |
Codexis Inc |
26 |
- |
$2.66 |
$6,100,000 |
2,000,000 |
0.6% |
5,533,000 |
1,700,000 |
3.083 |
Biotechnology |
|
|
TSVT |
2seventy Bio, Inc. |
27 |
- |
$0.00 |
$5,050,000 |
1,182,623 |
0.5% |
-2,884,000 |
-841,290 |
2.276 |
N/A |
|
|
ABSI |
Absci Corp |
28 |
- |
$4.58 |
$4,088,000 |
973,260 |
0.4% |
2,803,000 |
0 |
1.058 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
29 |
- |
$4.43 |
$3,253,000 |
367,175 |
0.32% |
-250,000 |
0 |
0.378 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
30 |
New |
$21.06 |
$3,242,000 |
150,000 |
0.32% |
3,242,000 |
150,000 |
0.195 |
N/A |
|
|
GLUE |
Monte Rosa Therapeutics, Inc. |
31 |
- |
$0.00 |
$2,886,000 |
510,882 |
0.28% |
439,000 |
0 |
1.148 |
N/A |
|
|
FLDM |
Fluidigm Corp |
32 |
- |
$2.44 |
$2,652,000 |
1,200,000 |
0.26% |
-828,000 |
0 |
1.619 |
Scientific & Technica... |
|
|
EXAI |
Exscientia Adr |
33 |
- |
$0.00 |
$1,371,000 |
213,900 |
0.14% |
404,000 |
0 |
0.178 |
N/A |
|
|
LIAN |
Lianbio |
34 |
- |
$0.00 |
$923,000 |
206,415 |
0.09% |
615,000 |
0 |
0.192 |
N/A |
|
|
OMIC |
Singular Genomics Systems, ... |
35 |
- |
$0.00 |
$609,000 |
1,323,885 |
0.06% |
105,000 |
0 |
1.85 |
N/A |
|
|
KRON |
Kronos Bio, Inc. |
36 |
- |
$0.00 |
$155,000 |
123,839 |
0.02% |
-6,000 |
0 |
0.221 |
N/A |
|
|
MXCT |
Maxcyte, Inc. |
40 |
Closed |
$3.71 |
$0 |
0 |
0% |
-5,897,000 |
-1,890,000 |
0 |
N/A |
|
|
MRTX |
Mirati Therapeutics, Inc. |
39 |
Closed |
$58.70 |
$0 |
0 |
0% |
-21,711,000 |
-498,427 |
0 |
Biotechnology |
|
|
SANA |
Sana Biotechnology, Inc. |
38 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,903,000 |
-750,000 |
0 |
N/A |
|
|
EQRX |
EQRx, Inc. |
37 |
Closed |
$2.34 |
$0 |
0 |
0% |
-87,751,000 |
-39,527,669 |
0 |
N/A |
|
